Semi-Annual Statement Of Cash Flows

TAKARA BIO INC. - Filing #7322771

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
4,361,000,000 JPY
46,028,000,000 JPY
Interest and dividends received
166,000,000 JPY
116,000,000 JPY
Interest paid
-22,000,000 JPY
-24,000,000 JPY
Income taxes paid
-2,359,000,000 JPY
-9,902,000,000 JPY
Net cash provided by (used in) operating activities
1,711,000,000 JPY
36,897,000,000 JPY
Cash flows from investing activities
Other, net
-19,000,000 JPY
7,000,000 JPY
Net cash provided by (used in) investing activities
-13,043,000,000 JPY
-6,693,000,000 JPY
Cash flows from financing activities
Dividends paid
-5,052,000,000 JPY
-3,968,000,000 JPY
Net cash provided by (used in) financing activities
-5,233,000,000 JPY
-4,119,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
678,000,000 JPY
813,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-15,886,000,000 JPY
26,897,000,000 JPY
Cash and cash equivalents
33,171,000,000 JPY
49,058,000,000 JPY
22,160,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.